Crown Aesthetics (Crown Laboratories) Acquires Select Assets from Healeon LLC (Bimini Health Tech)
July 23, 2024
Crown Aesthetics, a Crown Laboratories company, has acquired select assets and technology from Healeon LLC, a subsidiary of Bimini Health Tech, to strengthen its ProGen PRP Eclipse platelet-rich plasma (PRP) offering. The asset purchase expands Crown's PRP device portfolio, supports new product development, and aims to extend Crown's geographic and production capabilities in the regenerative and aesthetic medicine markets.
- Buyers
- Crown Aesthetics (a Crown Laboratories, Inc. company)
- Targets
- Select assets of Healeon LLC (a subsidiary of Bimini Health Tech)
- Sellers
- Healeon LLC, Bimini Health Tech
- Industry
- Medical Devices
- Location
- Texas, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Bimini Health Tech Acquires Healeon Medical, Inc.
June 16, 2020
Medical Devices
Bimini Health Tech has acquired Healeon Medical, Inc., adding Healeon's point-of-care PRP and adipose tissue processing medical devices to Bimini's regenerative medicine portfolio. The purchase expands Bimini's autologous product offering and brings Healeon's commercial PRP products and adipose pipeline under Bimini's global commercialization capabilities.
-
Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets
May 24, 2022
Medical Devices
Crown Laboratories has acquired the global, aesthetics-focused assets of Eclipse Medcorp, LLC, expanding Crown's aesthetics product portfolio and integrating Eclipse's devices into its Aesthetics business unit. The deal aims to broaden Crown's product offerings to aesthetics providers domestically and internationally and preserve service and medical-education support for Eclipse customers under Crown.
-
Crown Laboratories Acquires Revance Therapeutics in $924M Merger
August 12, 2024
Healthcare Services
Crown Laboratories, Inc. entered into a merger agreement to acquire Revance Therapeutics, Inc. for $6.66 per share in cash, representing an enterprise value of $924 million. The deal closed after Crown commenced a tender offer and then completed a second-step merger, with Revance becoming wholly owned by Crown and delisted from Nasdaq.
-
LPL Financial Acquires Crown Capital Securities' Wealth Management Business
May 8, 2024
Wealth Management
LPL Financial has closed its acquisition of the wealth management business of Crown Capital Securities, L.P., a full-service broker-dealer and registered investment advisor based in Orange County, California. Approximately 125 advisors representing about $1.3 billion of brokerage and advisory assets have been onboarded to LPL as of May 8, 2024, with roughly $3.7 billion expected to transfer in the coming months.
-
The Pritzker Organization Makes Growth Investment in Crown Health Care Laundry Services
March 8, 2021
Healthcare Services
The Pritzker Organization has made a growth investment in Crown Health Care Laundry Services, with affiliates of Quilvest Capital Partners selling their majority interests. Blenheim LP and Crown management remain significant shareholders; financial terms were not disclosed. The investment is intended to support Crown's next phase of growth, including expanding its customer base, geographic presence and facility network.
-
Astellas Pharma to Acquire Propella Therapeutics
November 15, 2023
Biotechnology
Astellas Pharma, through a US subsidiary, has entered into a merger agreement to acquire Propella Therapeutics for approximately $175 million in cash. Propella is developing PRL-02 (abiraterone decanoate), a next-generation long-acting prodrug targeting prostate cancer, which is currently in Phase 1 with plans to enter Phase 2a in 2024.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.